medline.ch ORL Hals

conid:1887
-kaloNeDinamik-------------------------------------------jo
-session-------------------------------------------Array
(
    [ID_S] => IP: 3.236.248.157; DATE: 2023/02/08/ 18:14:43
    [tip] => 2
    [contentType] => db
    [ses_userid] => 2
    [thisMode] => 
    [level_0] => 2
    [level_1] => 14
    [level_2] => 1
    [level_3] => 0
    [level_4] => 0
    [level] => 2
    [nodetype] => 2
    [node_family_id] => 0
    [monitor] => content
    [id_contentit_from_php_file] => 1887
    [uniqueid] => 2023020818144332362481571591
    [lang] => Lng1
    [contentId] => 1887
    [browser] => IE
    [clas_css] => 0
    [level_p] => 2
    [lng] => Lng1
    [nodetype_ci] => -1
    [usr] => 0
    [vazhdopunen] => po
    [search_for] => ("nasopharyngeal diseases"[Majr])  AND ("practice guideline" OR systematic[sb] OR "clinical trials"[mesh] OR "meta analysis"[pt] OR "epidemiologic studies"[mesh] OR randomi* OR "meta analysis" OR "evidence based" OR placebo* OR "single blind" OR "double blind" OR "control group" OR "triple blind" OR study[ti] OR studies[ti] OR trial[ti] OR trials[ti] OR consensus OR placebo OR review[pt] OR "sensitivity and specificity"[MeSH Terms] OR diagnos*[Ti] OR diagnosis[MeSH:noexp] OR diagnostic *[MeSH:noexp] OR diagnosis,differential[MeSH:noexp] OR diagnosis[Subheading:noexp] OR accuracy[Title/Abstract] OR "predictive value"[Title/Abstract]) AND (english[language] OR german[language] OR french[language] OR italian[language] OR spanish[language])  NOT veterinary[ti]
)

medline.ch ORL Hals

medline.ch

En | De

Impressum | Feedback

Sie sind hier: ORL » Hals

08. Februar 2023

Kardiovaskuläre Erkrankungen

Muskuloskelettale Erkrankungen

Schrift:

Seite 1 von 385


	Artikel 1 - 20 / 7681

	Development of a prognostic model to identify the metastatic nasopharyngeal carcinoma patients who may benefit from chemotherapy combination PD-1 inhibitor. Front Immunol Liu GY, Lu N, Bei WX, Li WZ, Liang H, Xia WX, Xiang YQ, Yao HR. PMID: 36733479 [PubMed - indexed for MEDLINE]
	The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma. Sci Rep Zhou J, Guo T, Zhou L, Bao M, Wang L, Zhou W, Tan S, Li G, He B, Guo Z. PMID: 36732567 [PubMed - indexed for MEDLINE]
	High proportion of circulating CD8â€‰+â€‰CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal canrcinoma after radiotherapy. J Transl Med Xu X, Wei F, Xiao L, Wu R, Wei B, Huang S, Yi J, Cui W. PMID: 36721233 [PubMed - indexed for MEDLINE]
	Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma. Front Immunol Li W, Duan X, Chen X, Zhan M, Peng H, Meng Y, Li X, Li XY, Pang G, Dou X. PMID: 36713430 [PubMed - indexed for MEDLINE]
	Immunohistochemical characteristics of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: A case report and review. Medicine (Baltimore) Guo H, Zhang Z, Huang C, Qiu J, Qu X. PMID: 36705380 [PubMed - indexed for MEDLINE]
	Induction chemotherapy with sequential nimotuzumab plus concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma: A retrospective real-world study. Medicine (Baltimore) Jiang D, Cao J, Guo L, Chen Y, Yuan G, Huang J. PMID: 36705354 [PubMed - indexed for MEDLINE]
	Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma. Biomed Res Int Li Z, Li C, Yang D, Zhou Z, Kang M. PMID: 36704722 [PubMed - indexed for MEDLINE]
	Fluorescent aptasensor based on the MNPs-CRISPR/Cas12a-TdT for the determination of nasopharyngeal carcinoma-derived exosomes. Mikrochim Acta Yi P, Luo D, Gao Z, Chen Q, Zhou Y. PMID: 36700990 [PubMed - indexed for MEDLINE]
	The utility of texture analysis based on quantitative synthetic magnetic resonance imaging in nasopharyngeal carcinoma: a preliminary study. BMC Med Imaging Yang F, Li Y, Li X, Yu X, Zhao Y, Li L, Xie L, Lin M. PMID: 36698156 [PubMed - indexed for MEDLINE]
	Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis. Radiat Oncol Yao Y, Sun X, Huang H, Wang Z, Fang X, Chen M, Chen Z, Weng H, Guo C, Hong H, Huang H, Lin T. PMID: 36681832 [PubMed - indexed for MEDLINE]
	The Dynamic Change in Plasma Epstein-Barr Virus DNA Load over a Long-Term Follow-Up Period Predicts Prognosis in Nasopharyngeal Carcinoma. Viruses Gihbid A, Benzeid R, Faouzi A, El Alami I, Tawfiq N, Benchakroun N, Bendahhou K, Benider A, Guensi A, Khaali W, Chaoui I, El Mzibri M, Cadi R, Khyatti M. PMID: 36680107 [PubMed - indexed for MEDLINE]
	The miRNA-185-5p/STIM1 Axis Regulates the Invasiveness of Nasopharyngeal Carcinoma Cell Lines by Modulating EGFR Activation-Stimulated Switch from E- to N-Cadherin. Molecules Luo Y, Ye J, Deng Y, Huang Y, Liu X, He Q, Chen Y, Li Q, Lin Y, Liang R, Li Y, Wei J, Zhang J. PMID: 36677874 [PubMed - indexed for MEDLINE]
	Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV. Medicina (Kaunas) Ahmed N, Abusalah MAHA, Farzand A, Absar M, Yusof NY, Rabaan AA, AlSaihati H, Alshengeti A, Alwarthan S, Alsuwailem HS, Alrumaih ZA, Alsayyah A, Yean CY. PMID: 36676626 [PubMed - indexed for MEDLINE]
	Effect of Percutaneous Endoscopic Gastrostomy on Quality of Life after Chemoradiation for Locally Advanced Nasopharyngeal Carcinoma: A Cross-Sectional Study. Curr Oncol Xu Y, Peng H, Guo Q, Guo L, Peng X, Lin S. PMID: 36661725 [PubMed - indexed for MEDLINE]
	Predicting Nomogram for Severe Oral Mucositis in Patients with Nasopharyngeal Carcinoma during Intensity-Modulated Radiation Therapy: A Retrospective Cohort Study. Curr Oncol Liu Z, Huang L, Wang H, Shi Z, Huang Y, Liang L, Wang R, Hu K. PMID: 36661666 [PubMed - indexed for MEDLINE]
	SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge. Indian J Pathol Microbiol Anila KR, Ginju V, Vishnu VL, Kumar R, Jayasree K. PMID: 36656230 [PubMed - indexed for MEDLINE]
	Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy and Survival of Patients With Low-Risk Nasopharyngeal Carcinoma. JAMA Liu Y, Zhang Y. PMID: 36648475 [PubMed - indexed for MEDLINE]
	Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy and Survival of Patients With Low-Risk Nasopharyngeal Carcinoma. JAMA Hu YT, Kao YS. PMID: 36648474 [PubMed - indexed for MEDLINE]
	Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy and Survival of Patients With Low-Risk Nasopharyngeal Carcinoma. JAMA Lin TA, Wei LJ, Ludmir EB. PMID: 36648473 [PubMed - indexed for MEDLINE]
	Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy and Survival of Patients With Low-Risk Nasopharyngeal Carcinoma-Reply. JAMA Guo R, Tang LL, Ma J. PMID: 36648471 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 7681

Seite 1 von 385

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung